Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model
Brain, Behavior, and Immunity · 2024
DOI: 10.1016/j.bbi.2024.06.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2024. Verfasst von Ying-Sui Lu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan; Taiwan International Graduate Program in Molecula…. Hauptthemen laut MEDLINE: Disease Models, Animal, Disease Progression, Huntington Disease, Microglia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by involuntary movements, cognitive deficits, and psychiatric symptoms. Currently, there is no cure, and only limited treatments are available to manage the symptoms and to slow down the disease's progression. The molecular and cellular mechanisms of HD's pathogenesis are complex, involving immune cell activation, altered protein turnover, and disturbance in brain energy homeostasis. Microglia have been known to play a dual role in HD, contributing to neurodegeneration through inflammation but also enacting neuroprotective effects by clearing mHTT aggregates. However, little is known about the contribution of microglial metabolism to HD progression. This study explores the impact of a microglial metabolite transporter, equilibrative nucleoside transporter 3 (ENT3), in HD. Known as a lysosomal membrane transporter protein, ENT3 is highly enriched in microglia, with its expression correlated with HD severity. Using the R6/2 ENT3-/- mouse model, we found that the deletion of ENT3 increases microglia numbers yet worsens HD progression, leading to mHTT accumulation, cell death, and disturbed energy metabolism. These results suggest that the delicate balance between microglial metabolism and function is crucial for maintaining brain homeostasis and that ENT3 has a protective role in ameliorating neurodegenerative processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan; Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sini…
- Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Taiwan International Graduate Program in Interdisciplinary Neuroscience, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, Taiwan.
- Institute of Microbiology and Immunology, National Yang Ming Chiao Tung University, Taipei, Taiwan; Biomedical Industry Ph.D. Program, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Zitieren
APA
Lu, Y. S., Hung, W. C., Hsieh, Y. T., Tsai, P. Y., Tsai, T. H., Fan, H. H., Chang, Y. G., Cheng, H. K., Huang, S. Y., Lin, H. C., Lee, Y. H., Shen, T. H., Hung, B. Y., Tsai, J. W., Dzhagalov, I., Cheng, I. H., Lin, C. J., Chern, Y., & Hsu, C. L. (2024). Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2024.06.021
Vancouver
Lu YS, Hung WC, Hsieh YT, Tsai PY, Tsai TH, Fan HH, et al. Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model. Brain, Behavior, and Immunity. 2024. doi:10.1016/j.bbi.2024.06.021
BibTeX
@article{Lu2024,
author = {Lu, Ying-Sui and Hung, Wei-Chien and Hsieh, Yu-Ting and Tsai, Pei-Yuan and Tsai, Tsai-Hsien and Fan, Hsiu-Han and Chang, Ya-Gin and Cheng, Hui-Kuei and Huang, Shen-Yan and Lin, Hsin-Chuan and Lee, Yan-Hua and Shen, Tzu-Hsiang and Hung, Bing-Yu and Tsai, Jin-Wu and Dzhagalov, Ivan and Cheng, Irene Han-Juo and Lin, Chun-Jung and Chern, Yijuang and Hsu, Chia-Lin},
title = {Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model},
journal = {Brain, Behavior, and Immunity},
year = {2024},
doi = {10.1016/j.bbi.2024.06.021}
}
EUVIMED